Clinical Research Directory
Browse clinical research sites, groups, and studies.
PK/PD Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections
Sponsor: University of Bologna
Summary
A multicenter, national, prospective, observational pharmacological study of patients with difficult-to-treat Gram-negative infections treated with ceftazidime/avibactam (CAZ/AVI) or cefiderocol (CEF) monotherapy or combination therapy with ceftazidime/avibactam associated with fosfomycin (FOS) or cefiderocol associated with fosfomycin.
Official title: Pharmacokinetic/Pharmacodynamic Analysis of Ceftazidime/Avibactam or Cefiderocol With or Without Fosfomycin for the Treatment of Difficult To-treat Gram-negative Infections
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
120
Start Date
2024-07-09
Completion Date
2025-09-30
Last Updated
2024-10-21
Healthy Volunteers
Yes
Locations (11)
Irccs Aoubo
Bologna, Italy
Azienda Ospedaliera di Rilievo Nazionale e di Alta Specializzazione (ARNAS) Garibaldi
Catania, Italy
ASST-FBF-Sacco
Milan, Italy
Azienda Ospedale - Università Padova
Padova, Italy
Istituto mediterraneo per i trapianti e terapie ad alta specializzazione (ISMETT)
Palermo, Italy
Policlinico Umberto I
Rome, Italy
Policlinico Universitario Campus Bio-Medico
Rome, Italy
Ospedale Pediatrico Bambin Gesù
Rome, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, Italy
Azienda Ospedaliero Universitaria Senese
Siena, Italy
Città della salute e della Scienza, Molinette
Turin, Italy